IFG Advisory LLC Has $978,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

IFG Advisory LLC lowered its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 4.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 7,199 shares of the financial services provider’s stock after selling 365 shares during the quarter. IFG Advisory LLC’s holdings in iShares Biotechnology ETF were worth $978,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the business. Activest Wealth Management bought a new position in iShares Biotechnology ETF during the 3rd quarter valued at $58,000. Householder Group Estate & Retirement Specialist LLC bought a new position in iShares Biotechnology ETF during the 3rd quarter valued at $60,000. HB Wealth Management LLC bought a new position in iShares Biotechnology ETF during the 3rd quarter valued at $219,000. Column Capital Advisors LLC bought a new position in iShares Biotechnology ETF during the 3rd quarter valued at $49,000. Finally, Premier Path Wealth Partners LLC bought a new position in iShares Biotechnology ETF during the 4th quarter valued at $207,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $137.79 on Thursday. The stock’s fifty day simple moving average is $136.42 and its two-hundred day simple moving average is $128.75. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were paid a dividend of $0.126 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.37%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.